H-1B sponsorship profile: CTRL Therapeutics USA Inc. Across U.S. Department of Labor LCA disclosures, CTRL Therapeutics USA Inc filed 5 Labor Condition Applications covering 5 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 80% (4 certified of 5 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on CTRL Therapeutics USA Inc’s H-1B petitions range from $127,566 at the low end to $160,500 at the high end, with a petition-weighted average of $146,213. That range reflects the mix of occupations the company sponsors, led by Senior R&D Engineer (2 petitions at $142,783 avg), followed by Senior Scientist, T Cell Engineering and Senior Scientist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. CTRL Therapeutics USA Inc is headquartered in Chicago, IL under NAICS code 541714, and places H-1B workers across 1 state, most heavily in IL. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where CTRL Therapeutics USA Inc ranks. By H-1B petition volume, CTRL Therapeutics USA Inc is #26,547 of 119,880 employers nationally and #1,287 of 5,284 employers headquartered in IL. Both ranks are computed live from the same underlying petition counts, not a separate estimate.